These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 26331709

  • 1. Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men.
    Yassin A, Almehmadi Y, Saad F, Doros G, Gooren L.
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):107-14. PubMed ID: 26331709
    [Abstract] [Full Text] [Related]

  • 2. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports.
    Saad F, Yassin A, Almehmadi Y, Doros G, Gooren L.
    Aging Male; 2015 Jan; 18(3):164-8. PubMed ID: 26075537
    [Abstract] [Full Text] [Related]

  • 3. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
    Yassin A, Nettleship JE, Talib RA, Almehmadi Y, Doros G.
    Aging Male; 2016 Jan; 19(1):64-9. PubMed ID: 26742589
    [Abstract] [Full Text] [Related]

  • 4. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G.
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [Abstract] [Full Text] [Related]

  • 5. Effects of continuous long-term testosterone therapy (TTh) on anthropometric, endocrine and metabolic parameters for up to 10 years in 115 hypogonadal elderly men: real-life experience from an observational registry study.
    Yassin AA, Nettleship J, Almehmadi Y, Salman M, Saad F.
    Andrologia; 2016 Sep; 48(7):793-9. PubMed ID: 26762680
    [Abstract] [Full Text] [Related]

  • 6. Effects of testosterone replacement therapy on metabolic syndrome among Japanese hypogonadal men: A subanalysis of a prospective randomised controlled trial (EARTH study).
    Shigehara K, Konaka H, Nohara T, Izumi K, Kitagawa Y, Kadono Y, Iwamoto T, Koh E, Mizokami A, Namiki M.
    Andrologia; 2018 Feb; 50(1):. PubMed ID: 28497534
    [Abstract] [Full Text] [Related]

  • 7. Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies.
    Saad F, Yassin A, Doros G, Haider A.
    Int J Obes (Lond); 2016 Jan; 40(1):162-70. PubMed ID: 26219417
    [Abstract] [Full Text] [Related]

  • 8. Long-term treatment patterns of testosterone replacement medications.
    Donatucci C, Cui Z, Fang Y, Muram D.
    J Sex Med; 2014 Aug; 11(8):2092-9. PubMed ID: 24909541
    [Abstract] [Full Text] [Related]

  • 9. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
    Giagulli VA, Carbone MD, Ramunni MI, Licchelli B, De Pergola G, Sabbà C, Guastamacchia E, Triggiani V.
    Andrology; 2015 Nov; 3(6):1094-103. PubMed ID: 26447645
    [Abstract] [Full Text] [Related]

  • 10. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM, Simhan J, Carson CC.
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [Abstract] [Full Text] [Related]

  • 11. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
    Grober ED, Lamb DJ, Khera M, Murthy L, Lipshultz LI.
    Int J Impot Res; 2008 May; 20(6):561-5. PubMed ID: 18843272
    [Abstract] [Full Text] [Related]

  • 12. Prospective assessment of health-related quality of life in men with late-onset hypogonadism who received testosterone replacement therapy.
    Sumii K, Miyake H, Enatsu N, Matsushita K, Fujisawa M.
    Andrologia; 2016 Mar; 48(2):198-202. PubMed ID: 25988884
    [Abstract] [Full Text] [Related]

  • 13. Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial.
    Khripun I, Vorobyev S, Belousov I, Kogan M, Zitzmann M.
    Aging Male; 2019 Dec; 22(4):241-249. PubMed ID: 30235049
    [Abstract] [Full Text] [Related]

  • 14. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
    Rosen RC, Wu F, Behre HM, Porst H, Meuleman EJH, Maggi M, Romero-Otero J, Martinez-Salamanca JI, Jones TH, Debruyne FMJ, Kurth KH, Hackett GI, Quinton R, Stroberg P, Reisman Y, Pescatori ES, Morales A, Bassas L, Cruz N, Cunningham GR, Wheaton OA, RHYME Investigators.
    J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
    [Abstract] [Full Text] [Related]

  • 15. Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapy.
    Salman M, Yassin DJ, Shoukfeh H, Nettleship JE, Yassin A.
    Aging Male; 2017 Mar; 20(1):45-48. PubMed ID: 28084147
    [Abstract] [Full Text] [Related]

  • 16. Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus.
    Shigehara K, Konaka H, Kato Y, Iijima M, Nakashima K, Kawaguchi S, Nohara T, Izumi K, Namiki M, Mizokami A.
    Int J Impot Res; 2019 Jan; 31(1):25-30. PubMed ID: 30135606
    [Abstract] [Full Text] [Related]

  • 17. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
    Wu XY, Mao JF, Lu SY, Zhang Q, Shi YF.
    Chin Med J (Engl); 2009 Dec 05; 122(23):2846-50. PubMed ID: 20092788
    [Abstract] [Full Text] [Related]

  • 18. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.
    Borst SE, Yarrow JF.
    Am J Physiol Endocrinol Metab; 2015 Jun 15; 308(12):E1035-42. PubMed ID: 25898953
    [Abstract] [Full Text] [Related]

  • 19. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
    Lundy SD, Parekh NV, Shoskes DA.
    J Sex Med; 2020 Jul 15; 17(7):1297-1303. PubMed ID: 32307242
    [Abstract] [Full Text] [Related]

  • 20. Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study).
    Shigehara K, Konaka H, Koh E, Nakashima K, Iijima M, Nohara T, Izumi K, Kitagawa Y, Kadono Y, Sugimoto K, Iwamoto T, Mizokami A, Namiki M.
    Aging Male; 2017 Sep 15; 20(3):139-145. PubMed ID: 28347184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.